Contrary to protective effects observed in all other tissues, as noted earlier, SIRT3 mediates estrogen-dependent bone loss, with its absence mitigating age- and hormone-related bone deterioration, particularly in females [15], making it a potential target in postmenopausal osteoporosis. This evidence concerns the gene SIRT3 and postmenopausal osteoporosis.